tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Katie Tryhane, 1 are a BUY (100%).
Analyst Katie Tryhane, currently employed
Katie Tryhane’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$227
$40.84 (21.94%)
$203
1 months 22 days ago
(11-Nov-2024)
4/5 (80%)
$6.45 (2.92%)
44
Buy
$190
$3.84 (2.06%)
$190
2 months 26 days ago
(07-Oct-2024)
2/3 (66.67%)
$0.78 (0.41%)
8
Hold
$190
$3.84 (2.06%)
$191
3 months 13 days ago
(20-Sep-2024)
10/13 (76.92%)
$-15.79 (-7.67%)
73
Buy
$290
6 months 5 days ago
(28-Jun-2024)
5/7 (71.43%)
$27.87 (10.63%)
136
Buy
$265
$78.84 (42.35%)
10 months 18 days ago
(15-Feb-2024)
3/3 (100%)
$19.6 (7.99%)
114
What Year was the first public recommendation made by Katie Tryhane?
